MIM
ZBH icon

MTM Investment Management’s Zimmer Biomet ZBH Stock Holding History

MTM Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44K Sell
98
-50
-34% -$4.38K ﹤0.01% 549
2026
Q1 		$13.4K Hold
148
– – ﹤0.01% 484
2025
Q4 		$13.3K Hold
148
– – ﹤0.01% 494
2025
Q3 		$14.6K Hold
148
– – ﹤0.01% 495
2025
Q2 		$13.5K Buy
+148
New +$14.3K ﹤0.01% 504

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MTM Investment Management's ZBH Position: Q2 2026 in Review

MTM Investment Management reduced its Zimmer Biomet (ZBH) stake by 34% in Q2 2026, selling an estimated $4.38K and leaving 98 shares worth $8.44K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

MTM Investment Management first reported a position in ZBH in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.6K in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • MTM Investment Management held 98 shares of Zimmer Biomet worth $8.44K as of Q2 2026.
  • MTM Investment Management sold 50 Zimmer Biomet shares in Q2 2026, an estimated $4.38K.
  • Zimmer Biomet made up ﹤0.01% of MTM Investment Management's portfolio in Q2 2026, its #549 holding.
  • MTM Investment Management first reported a position in Zimmer Biomet in Q2 2025 and has held it in 5 quarters since.
  • MTM Investment Management's Zimmer Biomet position peaked at $14.6K in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.